NDC properties for "60 ACTUAT testosterone 30 MG/1.5 ML ACTUAT Topical Solution" (RxCUI 1599949)
About this data
The tables show NDC propoerties for 60 ACTUAT testosterone 30 MG/1.5 ML ACTUAT Topical Solution with the RxCUI 1599949
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product
Details for 60 ACTUAT testosterone 30 MG/1.5 ML ACTUAT Topical Solution (RxCUI 1599949)
| ANDA | ANDA204255 |
|---|---|
| ANDA | ANDA205328 |
| ANDA | ANDA208061 |
| ANDA | ANDA209533 |
| ANDA | ANDA209836 |
| ANDA | ANDA212882 |
| MMSL_CODE | BD26663 |
| RxCUI | 1599949 |
| SPL_SET_ID | 0e943d17-3bf1-405a-9830-27653bfbf44b |
| SPL_SET_ID | 29c8846f-121c-4958-9e03-3bd271c21558 |
| SPL_SET_ID | 5be74193-de73-436d-a9a1-35a857bc8e0c |
| SPL_SET_ID | 6a46b5de-5d95-4570-91a6-3e4278028c59 |
| SPL_SET_ID | 7227ab2f-c8ef-4bab-92ab-3092182abcc9 |
| SPL_SET_ID | 9fe3a833-d9eb-4559-9b9e-1379ec4487a0 |
| SPL_SET_ID | c0c56607-e995-4bed-9c62-e33a722b38b5 |
| SPL_SET_ID | d22a072f-529b-4878-90fc-4365d9dc67e6 |
| SPL_SET_ID | e39289aa-681c-47ec-9461-52e7f17e5d71 |
| VUID | 4030662 |
| Prescribable Synonym | testosterone 2 % (30 MG/ACTUAT) Topical Solution, 60 ACTUAT |
| RXNAV_STR | 60 ACTUAT testosterone 30 MG/ACTUAT Topical Solution |
| RxNorm Name | 60 ACTUAT testosterone 30 MG/ACTUAT Topical Solution |
| RxNorm Synonym | 60 ACTUAT testosterone 30 MG/1.5 ML ACTUAT Topical Solution |
| RxNorm Synonym | testosterone (as testosterone propionate) 2 % Topical Solution |
| RxNorm Synonym | testosterone 2 % (30 MG/ACTUAT) Topical Solution, 60 ACTUAT |
| Related queries | Interactions (for RxCUI 1599949) |
NDC Properties
NDC Item 00591211481
| NDC 9 | 0591-2114 |
|---|---|
| NDC 10 | 0591-2114-81 |
| NDC Item | 00591211481 |
| Packaging | 1 BOTTLE, WITH APPLICATOR in 1 CARTON (0591-2114-81) / 90 mL in 1 BOTTLE, WITH APPLICATOR |
| ANDA | ANDA205328 |
| DCSA | CIII |
| FDA SPL set id | 673536 |
| Labeler | Actavis Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-08-18 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0591-2114 |
NDC Item 24979013026
| NDC 9 | 24979-130 |
|---|---|
| NDC 10 | 24979-130-26 |
| NDC Item | 24979013026 |
| Packaging | 1 BOTTLE, PUMP in 1 CARTON (24979-130-26) / 110 mL in 1 BOTTLE, PUMP |
| ANDA | ANDA209836 |
| DCSA | CIII |
| FDA SPL set id | 750432 |
| Labeler | TWi Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-12-31 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 24979-130 |
NDC Item 45802061001
| NDC 9 | 45802-610 |
|---|---|
| NDC 10 | 45802-610-01 |
| NDC Item | 45802061001 |
| Packaging | 1 BOTTLE, PUMP in 1 CARTON (45802-610-01) / 110 mL in 1 BOTTLE, PUMP |
| ANDA | ANDA204255 |
| DCSA | CIII |
| FDA SPL set id | 700458 |
| Labeler | Padagis Israel Pharmaceuticals Ltd |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-06-28 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 45802-610 |
NDC Item 62332048811
| NDC 9 | 62332-488 |
|---|---|
| NDC 10 | 62332-488-11 |
| NDC Item | 62332048811 |
| Packaging | 1 BOTTLE, WITH APPLICATOR in 1 CARTON (62332-488-11) / 110 mL in 1 BOTTLE, WITH APPLICATOR |
| ANDA | ANDA212882 |
| DCSA | CIII |
| FDA SPL set id | 752837 |
| Labeler | Alembic Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-12-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 62332-488 |
NDC Item 63629931001
| NDC 9 | 63629-9310 |
|---|---|
| NDC 10 | 63629-9310-1 |
| NDC Item | 63629931001 |
| Packaging | 1 BOTTLE, PUMP in 1 CARTON (63629-9310-1) / 110 mL in 1 BOTTLE, PUMP |
| ANDA | ANDA204255 |
| DCSA | CIII |
| FDA SPL set id | 805065 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-06-28 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63629-9310 |
NDC Item 66993096389
| NDC 9 | 66993-963 |
|---|---|
| NDC 10 | 66993-963-89 |
| NDC Item | 66993096389 |
| Packaging | 1 BOTTLE, WITH APPLICATOR in 1 CARTON (66993-963-89) / 90 mL in 1 BOTTLE, WITH APPLICATOR |
| DCSA | CIII |
| FDA SPL set id | 327477 |
| Labeler | Prasco Laboratories |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time high | 2018-12-31 |
| Marketing effective time low | 2017-01-23 |
| Marketing status | COMPLETED |
| NDA_AUTHORIZED_GENERIC | NDA022504 |
| Related queries | Properties for NDC 9 66993-963 |
NDC Item 68180094311
| NDC 9 | 68180-943 |
|---|---|
| NDC 10 | 68180-943-11 |
| NDC Item | 68180094311 |
| Packaging | 1 BOTTLE, WITH APPLICATOR in 1 CARTON (68180-943-11) / 90 mL in 1 BOTTLE, WITH APPLICATOR |
| ANDA | ANDA208061 |
| DCSA | CIII |
| FDA SPL set id | 468196 |
| Labeler | Lupin Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2018-02-23 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68180-943 |
NDC Item 69097036344
| NDC 9 | 69097-363 |
|---|---|
| NDC 10 | 69097-363-44 |
| NDC Item | 69097036344 |
| Packaging | 1 BOTTLE in 1 CARTON (69097-363-44) / 90 mL in 1 BOTTLE |
| ANDA | ANDA209533 |
| DCSA | CIII |
| FDA SPL set id | 497849 |
| Labeler | Cipla USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2018-03-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 69097-363 |
NDC Item 69339015810
| NDC 9 | 69339-158 |
|---|---|
| NDC 10 | 69339-158-10 |
| NDC Item | 69339015810 |
| Packaging | 1 BOTTLE in 1 CARTON (69339-158-10) / 110 mL in 1 BOTTLE |
| ANDA | ANDA212301 |
| DCSA | CIII |
| FDA SPL set id | 776899 |
| Labeler | NATCO Pharma USA LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2024-03-31 |
| Marketing effective time low | 2021-07-12 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 69339-158 |
NDC Item 72162142102
| NDC 9 | 72162-1421 |
|---|---|
| NDC 10 | 72162-1421-2 |
| NDC Item | 72162142102 |
| Packaging | 1 BOTTLE, PUMP in 1 CARTON (72162-1421-2) / 110 mL in 1 BOTTLE, PUMP |
| ANDA | ANDA204255 |
| DCSA | CIII |
| FDA SPL set id | 793241 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-06-28 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72162-1421 |
NDC Item 00591211481
| NDC 9 | 0591-2114 |
|---|---|
| NDC 10 | 0591-2114-81 |
| NDC Item | 00591211481 |
| Packaging | 1 BOTTLE, WITH APPLICATOR in 1 CARTON (0591-2114-81) / 90 mL in 1 BOTTLE, WITH APPLICATOR |
| ANDA | ANDA205328 |
| DCSA | CIII |
| FDA SPL set id | 673536 |
| Labeler | Actavis Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-08-18 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0591-2114 |
NDC Item 24979013026
| NDC 9 | 24979-130 |
|---|---|
| NDC 10 | 24979-130-26 |
| NDC Item | 24979013026 |
| Packaging | 1 BOTTLE, PUMP in 1 CARTON (24979-130-26) / 110 mL in 1 BOTTLE, PUMP |
| ANDA | ANDA209836 |
| DCSA | CIII |
| FDA SPL set id | 750432 |
| Labeler | TWi Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-12-31 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 24979-130 |
NDC Item 45802061001
| NDC 9 | 45802-610 |
|---|---|
| NDC 10 | 45802-610-01 |
| NDC Item | 45802061001 |
| Packaging | 1 BOTTLE, PUMP in 1 CARTON (45802-610-01) / 110 mL in 1 BOTTLE, PUMP |
| ANDA | ANDA204255 |
| DCSA | CIII |
| FDA SPL set id | 700458 |
| Labeler | Padagis Israel Pharmaceuticals Ltd |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-06-28 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 45802-610 |
NDC Item 62332048811
| NDC 9 | 62332-488 |
|---|---|
| NDC 10 | 62332-488-11 |
| NDC Item | 62332048811 |
| Packaging | 1 BOTTLE, WITH APPLICATOR in 1 CARTON (62332-488-11) / 110 mL in 1 BOTTLE, WITH APPLICATOR |
| ANDA | ANDA212882 |
| DCSA | CIII |
| FDA SPL set id | 752837 |
| Labeler | Alembic Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-12-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 62332-488 |
NDC Item 63629931001
| NDC 9 | 63629-9310 |
|---|---|
| NDC 10 | 63629-9310-1 |
| NDC Item | 63629931001 |
| Packaging | 1 BOTTLE, PUMP in 1 CARTON (63629-9310-1) / 110 mL in 1 BOTTLE, PUMP |
| ANDA | ANDA204255 |
| DCSA | CIII |
| FDA SPL set id | 805065 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-06-28 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63629-9310 |
NDC Item 66993096389
| NDC 9 | 66993-963 |
|---|---|
| NDC 10 | 66993-963-89 |
| NDC Item | 66993096389 |
| Packaging | 1 BOTTLE, WITH APPLICATOR in 1 CARTON (66993-963-89) / 90 mL in 1 BOTTLE, WITH APPLICATOR |
| DCSA | CIII |
| FDA SPL set id | 327477 |
| Labeler | Prasco Laboratories |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time high | 2018-12-31 |
| Marketing effective time low | 2017-01-23 |
| Marketing status | COMPLETED |
| NDA_AUTHORIZED_GENERIC | NDA022504 |
| Related queries | Properties for NDC 9 66993-963 |
NDC Item 68180094311
| NDC 9 | 68180-943 |
|---|---|
| NDC 10 | 68180-943-11 |
| NDC Item | 68180094311 |
| Packaging | 1 BOTTLE, WITH APPLICATOR in 1 CARTON (68180-943-11) / 90 mL in 1 BOTTLE, WITH APPLICATOR |
| ANDA | ANDA208061 |
| DCSA | CIII |
| FDA SPL set id | 468196 |
| Labeler | Lupin Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2018-02-23 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68180-943 |
NDC Item 69097036344
| NDC 9 | 69097-363 |
|---|---|
| NDC 10 | 69097-363-44 |
| NDC Item | 69097036344 |
| Packaging | 1 BOTTLE in 1 CARTON (69097-363-44) / 90 mL in 1 BOTTLE |
| ANDA | ANDA209533 |
| DCSA | CIII |
| FDA SPL set id | 497849 |
| Labeler | Cipla USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2018-03-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 69097-363 |
NDC Item 69339015810
| NDC 9 | 69339-158 |
|---|---|
| NDC 10 | 69339-158-10 |
| NDC Item | 69339015810 |
| Packaging | 1 BOTTLE in 1 CARTON (69339-158-10) / 110 mL in 1 BOTTLE |
| ANDA | ANDA212301 |
| DCSA | CIII |
| FDA SPL set id | 776899 |
| Labeler | NATCO Pharma USA LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2024-03-31 |
| Marketing effective time low | 2021-07-12 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 69339-158 |
NDC Item 72162142102
| NDC 9 | 72162-1421 |
|---|---|
| NDC 10 | 72162-1421-2 |
| NDC Item | 72162142102 |
| Packaging | 1 BOTTLE, PUMP in 1 CARTON (72162-1421-2) / 110 mL in 1 BOTTLE, PUMP |
| ANDA | ANDA204255 |
| DCSA | CIII |
| FDA SPL set id | 793241 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-06-28 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72162-1421 |
NDC Item 00591211481
| NDC 9 | 0591-2114 |
|---|---|
| NDC 10 | 0591-2114-81 |
| NDC Item | 00591211481 |
| Packaging | 1 BOTTLE, WITH APPLICATOR in 1 CARTON (0591-2114-81) / 90 mL in 1 BOTTLE, WITH APPLICATOR |
| ANDA | ANDA205328 |
| DCSA | CIII |
| FDA SPL set id | 673536 |
| Labeler | Actavis Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-08-18 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0591-2114 |
NDC Item 24979013026
| NDC 9 | 24979-130 |
|---|---|
| NDC 10 | 24979-130-26 |
| NDC Item | 24979013026 |
| Packaging | 1 BOTTLE, PUMP in 1 CARTON (24979-130-26) / 110 mL in 1 BOTTLE, PUMP |
| ANDA | ANDA209836 |
| DCSA | CIII |
| FDA SPL set id | 750432 |
| Labeler | TWi Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-12-31 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 24979-130 |
NDC Item 45802061001
| NDC 9 | 45802-610 |
|---|---|
| NDC 10 | 45802-610-01 |
| NDC Item | 45802061001 |
| Packaging | 1 BOTTLE, PUMP in 1 CARTON (45802-610-01) / 110 mL in 1 BOTTLE, PUMP |
| ANDA | ANDA204255 |
| DCSA | CIII |
| FDA SPL set id | 700458 |
| Labeler | Padagis Israel Pharmaceuticals Ltd |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-06-28 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 45802-610 |
NDC Item 62332048811
| NDC 9 | 62332-488 |
|---|---|
| NDC 10 | 62332-488-11 |
| NDC Item | 62332048811 |
| Packaging | 1 BOTTLE, WITH APPLICATOR in 1 CARTON (62332-488-11) / 110 mL in 1 BOTTLE, WITH APPLICATOR |
| ANDA | ANDA212882 |
| DCSA | CIII |
| FDA SPL set id | 752837 |
| Labeler | Alembic Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-12-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 62332-488 |
NDC Item 63629931001
| NDC 9 | 63629-9310 |
|---|---|
| NDC 10 | 63629-9310-1 |
| NDC Item | 63629931001 |
| Packaging | 1 BOTTLE, PUMP in 1 CARTON (63629-9310-1) / 110 mL in 1 BOTTLE, PUMP |
| ANDA | ANDA204255 |
| DCSA | CIII |
| FDA SPL set id | 805065 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-06-28 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63629-9310 |
NDC Item 66993096389
| NDC 9 | 66993-963 |
|---|---|
| NDC 10 | 66993-963-89 |
| NDC Item | 66993096389 |
| Packaging | 1 BOTTLE, WITH APPLICATOR in 1 CARTON (66993-963-89) / 90 mL in 1 BOTTLE, WITH APPLICATOR |
| DCSA | CIII |
| FDA SPL set id | 327477 |
| Labeler | Prasco Laboratories |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time high | 2018-12-31 |
| Marketing effective time low | 2017-01-23 |
| Marketing status | COMPLETED |
| NDA_AUTHORIZED_GENERIC | NDA022504 |
| Related queries | Properties for NDC 9 66993-963 |
NDC Item 68180094311
| NDC 9 | 68180-943 |
|---|---|
| NDC 10 | 68180-943-11 |
| NDC Item | 68180094311 |
| Packaging | 1 BOTTLE, WITH APPLICATOR in 1 CARTON (68180-943-11) / 90 mL in 1 BOTTLE, WITH APPLICATOR |
| ANDA | ANDA208061 |
| DCSA | CIII |
| FDA SPL set id | 468196 |
| Labeler | Lupin Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2018-02-23 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68180-943 |
NDC Item 69097036344
| NDC 9 | 69097-363 |
|---|---|
| NDC 10 | 69097-363-44 |
| NDC Item | 69097036344 |
| Packaging | 1 BOTTLE in 1 CARTON (69097-363-44) / 90 mL in 1 BOTTLE |
| ANDA | ANDA209533 |
| DCSA | CIII |
| FDA SPL set id | 497849 |
| Labeler | Cipla USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2018-03-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 69097-363 |
NDC Item 69339015810
| NDC 9 | 69339-158 |
|---|---|
| NDC 10 | 69339-158-10 |
| NDC Item | 69339015810 |
| Packaging | 1 BOTTLE in 1 CARTON (69339-158-10) / 110 mL in 1 BOTTLE |
| ANDA | ANDA212301 |
| DCSA | CIII |
| FDA SPL set id | 776899 |
| Labeler | NATCO Pharma USA LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2024-03-31 |
| Marketing effective time low | 2021-07-12 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 69339-158 |
NDC Item 72162142102
| NDC 9 | 72162-1421 |
|---|---|
| NDC 10 | 72162-1421-2 |
| NDC Item | 72162142102 |
| Packaging | 1 BOTTLE, PUMP in 1 CARTON (72162-1421-2) / 110 mL in 1 BOTTLE, PUMP |
| ANDA | ANDA204255 |
| DCSA | CIII |
| FDA SPL set id | 793241 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-06-28 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72162-1421 |
NDC Item 00591211481
| NDC 9 | 0591-2114 |
|---|---|
| NDC 10 | 0591-2114-81 |
| NDC Item | 00591211481 |
| Packaging | 1 BOTTLE, WITH APPLICATOR in 1 CARTON (0591-2114-81) / 90 mL in 1 BOTTLE, WITH APPLICATOR |
| ANDA | ANDA205328 |
| DCSA | CIII |
| FDA SPL set id | 673536 |
| Labeler | Actavis Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-08-18 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0591-2114 |
NDC Item 24979013026
| NDC 9 | 24979-130 |
|---|---|
| NDC 10 | 24979-130-26 |
| NDC Item | 24979013026 |
| Packaging | 1 BOTTLE, PUMP in 1 CARTON (24979-130-26) / 110 mL in 1 BOTTLE, PUMP |
| ANDA | ANDA209836 |
| DCSA | CIII |
| FDA SPL set id | 750432 |
| Labeler | TWi Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-12-31 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 24979-130 |
NDC Item 45802061001
| NDC 9 | 45802-610 |
|---|---|
| NDC 10 | 45802-610-01 |
| NDC Item | 45802061001 |
| Packaging | 1 BOTTLE, PUMP in 1 CARTON (45802-610-01) / 110 mL in 1 BOTTLE, PUMP |
| ANDA | ANDA204255 |
| DCSA | CIII |
| FDA SPL set id | 700458 |
| Labeler | Padagis Israel Pharmaceuticals Ltd |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-06-28 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 45802-610 |
NDC Item 62332048811
| NDC 9 | 62332-488 |
|---|---|
| NDC 10 | 62332-488-11 |
| NDC Item | 62332048811 |
| Packaging | 1 BOTTLE, WITH APPLICATOR in 1 CARTON (62332-488-11) / 110 mL in 1 BOTTLE, WITH APPLICATOR |
| ANDA | ANDA212882 |
| DCSA | CIII |
| FDA SPL set id | 752837 |
| Labeler | Alembic Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-12-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 62332-488 |
NDC Item 63629931001
| NDC 9 | 63629-9310 |
|---|---|
| NDC 10 | 63629-9310-1 |
| NDC Item | 63629931001 |
| Packaging | 1 BOTTLE, PUMP in 1 CARTON (63629-9310-1) / 110 mL in 1 BOTTLE, PUMP |
| ANDA | ANDA204255 |
| DCSA | CIII |
| FDA SPL set id | 805065 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-06-28 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63629-9310 |
NDC Item 66993096389
| NDC 9 | 66993-963 |
|---|---|
| NDC 10 | 66993-963-89 |
| NDC Item | 66993096389 |
| Packaging | 1 BOTTLE, WITH APPLICATOR in 1 CARTON (66993-963-89) / 90 mL in 1 BOTTLE, WITH APPLICATOR |
| DCSA | CIII |
| FDA SPL set id | 327477 |
| Labeler | Prasco Laboratories |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time high | 2018-12-31 |
| Marketing effective time low | 2017-01-23 |
| Marketing status | COMPLETED |
| NDA_AUTHORIZED_GENERIC | NDA022504 |
| Related queries | Properties for NDC 9 66993-963 |
NDC Item 68180094311
| NDC 9 | 68180-943 |
|---|---|
| NDC 10 | 68180-943-11 |
| NDC Item | 68180094311 |
| Packaging | 1 BOTTLE, WITH APPLICATOR in 1 CARTON (68180-943-11) / 90 mL in 1 BOTTLE, WITH APPLICATOR |
| ANDA | ANDA208061 |
| DCSA | CIII |
| FDA SPL set id | 468196 |
| Labeler | Lupin Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2018-02-23 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68180-943 |
NDC Item 69097036344
| NDC 9 | 69097-363 |
|---|---|
| NDC 10 | 69097-363-44 |
| NDC Item | 69097036344 |
| Packaging | 1 BOTTLE in 1 CARTON (69097-363-44) / 90 mL in 1 BOTTLE |
| ANDA | ANDA209533 |
| DCSA | CIII |
| FDA SPL set id | 497849 |
| Labeler | Cipla USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2018-03-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 69097-363 |
NDC Item 69339015810
| NDC 9 | 69339-158 |
|---|---|
| NDC 10 | 69339-158-10 |
| NDC Item | 69339015810 |
| Packaging | 1 BOTTLE in 1 CARTON (69339-158-10) / 110 mL in 1 BOTTLE |
| ANDA | ANDA212301 |
| DCSA | CIII |
| FDA SPL set id | 776899 |
| Labeler | NATCO Pharma USA LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2024-03-31 |
| Marketing effective time low | 2021-07-12 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 69339-158 |
NDC Item 72162142102
| NDC 9 | 72162-1421 |
|---|---|
| NDC 10 | 72162-1421-2 |
| NDC Item | 72162142102 |
| Packaging | 1 BOTTLE, PUMP in 1 CARTON (72162-1421-2) / 110 mL in 1 BOTTLE, PUMP |
| ANDA | ANDA204255 |
| DCSA | CIII |
| FDA SPL set id | 793241 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-06-28 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72162-1421 |
NDC Item 00591211481
| NDC 9 | 0591-2114 |
|---|---|
| NDC 10 | 0591-2114-81 |
| NDC Item | 00591211481 |
| Packaging | 1 BOTTLE, WITH APPLICATOR in 1 CARTON (0591-2114-81) / 90 mL in 1 BOTTLE, WITH APPLICATOR |
| ANDA | ANDA205328 |
| DCSA | CIII |
| FDA SPL set id | 673536 |
| Labeler | Actavis Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-08-18 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0591-2114 |
NDC Item 24979013026
| NDC 9 | 24979-130 |
|---|---|
| NDC 10 | 24979-130-26 |
| NDC Item | 24979013026 |
| Packaging | 1 BOTTLE, PUMP in 1 CARTON (24979-130-26) / 110 mL in 1 BOTTLE, PUMP |
| ANDA | ANDA209836 |
| DCSA | CIII |
| FDA SPL set id | 750432 |
| Labeler | TWi Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-12-31 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 24979-130 |
NDC Item 45802061001
| NDC 9 | 45802-610 |
|---|---|
| NDC 10 | 45802-610-01 |
| NDC Item | 45802061001 |
| Packaging | 1 BOTTLE, PUMP in 1 CARTON (45802-610-01) / 110 mL in 1 BOTTLE, PUMP |
| ANDA | ANDA204255 |
| DCSA | CIII |
| FDA SPL set id | 700458 |
| Labeler | Padagis Israel Pharmaceuticals Ltd |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-06-28 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 45802-610 |
NDC Item 62332048811
| NDC 9 | 62332-488 |
|---|---|
| NDC 10 | 62332-488-11 |
| NDC Item | 62332048811 |
| Packaging | 1 BOTTLE, WITH APPLICATOR in 1 CARTON (62332-488-11) / 110 mL in 1 BOTTLE, WITH APPLICATOR |
| ANDA | ANDA212882 |
| DCSA | CIII |
| FDA SPL set id | 752837 |
| Labeler | Alembic Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-12-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 62332-488 |
NDC Item 63629931001
| NDC 9 | 63629-9310 |
|---|---|
| NDC 10 | 63629-9310-1 |
| NDC Item | 63629931001 |
| Packaging | 1 BOTTLE, PUMP in 1 CARTON (63629-9310-1) / 110 mL in 1 BOTTLE, PUMP |
| ANDA | ANDA204255 |
| DCSA | CIII |
| FDA SPL set id | 805065 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-06-28 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63629-9310 |
NDC Item 66993096389
| NDC 9 | 66993-963 |
|---|---|
| NDC 10 | 66993-963-89 |
| NDC Item | 66993096389 |
| Packaging | 1 BOTTLE, WITH APPLICATOR in 1 CARTON (66993-963-89) / 90 mL in 1 BOTTLE, WITH APPLICATOR |
| DCSA | CIII |
| FDA SPL set id | 327477 |
| Labeler | Prasco Laboratories |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time high | 2018-12-31 |
| Marketing effective time low | 2017-01-23 |
| Marketing status | COMPLETED |
| NDA_AUTHORIZED_GENERIC | NDA022504 |
| Related queries | Properties for NDC 9 66993-963 |
NDC Item 68180094311
| NDC 9 | 68180-943 |
|---|---|
| NDC 10 | 68180-943-11 |
| NDC Item | 68180094311 |
| Packaging | 1 BOTTLE, WITH APPLICATOR in 1 CARTON (68180-943-11) / 90 mL in 1 BOTTLE, WITH APPLICATOR |
| ANDA | ANDA208061 |
| DCSA | CIII |
| FDA SPL set id | 468196 |
| Labeler | Lupin Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2018-02-23 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68180-943 |
NDC Item 69097036344
| NDC 9 | 69097-363 |
|---|---|
| NDC 10 | 69097-363-44 |
| NDC Item | 69097036344 |
| Packaging | 1 BOTTLE in 1 CARTON (69097-363-44) / 90 mL in 1 BOTTLE |
| ANDA | ANDA209533 |
| DCSA | CIII |
| FDA SPL set id | 497849 |
| Labeler | Cipla USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2018-03-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 69097-363 |
NDC Item 69339015810
| NDC 9 | 69339-158 |
|---|---|
| NDC 10 | 69339-158-10 |
| NDC Item | 69339015810 |
| Packaging | 1 BOTTLE in 1 CARTON (69339-158-10) / 110 mL in 1 BOTTLE |
| ANDA | ANDA212301 |
| DCSA | CIII |
| FDA SPL set id | 776899 |
| Labeler | NATCO Pharma USA LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2024-03-31 |
| Marketing effective time low | 2021-07-12 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 69339-158 |
NDC Item 72162142102
| NDC 9 | 72162-1421 |
|---|---|
| NDC 10 | 72162-1421-2 |
| NDC Item | 72162142102 |
| Packaging | 1 BOTTLE, PUMP in 1 CARTON (72162-1421-2) / 110 mL in 1 BOTTLE, PUMP |
| ANDA | ANDA204255 |
| DCSA | CIII |
| FDA SPL set id | 793241 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-06-28 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72162-1421 |
NDC Item 00591211481
| NDC 9 | 0591-2114 |
|---|---|
| NDC 10 | 0591-2114-81 |
| NDC Item | 00591211481 |
| Packaging | 1 BOTTLE, WITH APPLICATOR in 1 CARTON (0591-2114-81) / 90 mL in 1 BOTTLE, WITH APPLICATOR |
| ANDA | ANDA205328 |
| DCSA | CIII |
| FDA SPL set id | 673536 |
| Labeler | Actavis Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-08-18 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0591-2114 |
NDC Item 24979013026
| NDC 9 | 24979-130 |
|---|---|
| NDC 10 | 24979-130-26 |
| NDC Item | 24979013026 |
| Packaging | 1 BOTTLE, PUMP in 1 CARTON (24979-130-26) / 110 mL in 1 BOTTLE, PUMP |
| ANDA | ANDA209836 |
| DCSA | CIII |
| FDA SPL set id | 750432 |
| Labeler | TWi Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-12-31 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 24979-130 |
NDC Item 45802061001
| NDC 9 | 45802-610 |
|---|---|
| NDC 10 | 45802-610-01 |
| NDC Item | 45802061001 |
| Packaging | 1 BOTTLE, PUMP in 1 CARTON (45802-610-01) / 110 mL in 1 BOTTLE, PUMP |
| ANDA | ANDA204255 |
| DCSA | CIII |
| FDA SPL set id | 700458 |
| Labeler | Padagis Israel Pharmaceuticals Ltd |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-06-28 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 45802-610 |
NDC Item 62332048811
| NDC 9 | 62332-488 |
|---|---|
| NDC 10 | 62332-488-11 |
| NDC Item | 62332048811 |
| Packaging | 1 BOTTLE, WITH APPLICATOR in 1 CARTON (62332-488-11) / 110 mL in 1 BOTTLE, WITH APPLICATOR |
| ANDA | ANDA212882 |
| DCSA | CIII |
| FDA SPL set id | 752837 |
| Labeler | Alembic Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-12-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 62332-488 |
NDC Item 63629931001
| NDC 9 | 63629-9310 |
|---|---|
| NDC 10 | 63629-9310-1 |
| NDC Item | 63629931001 |
| Packaging | 1 BOTTLE, PUMP in 1 CARTON (63629-9310-1) / 110 mL in 1 BOTTLE, PUMP |
| ANDA | ANDA204255 |
| DCSA | CIII |
| FDA SPL set id | 805065 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-06-28 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63629-9310 |
NDC Item 66993096389
| NDC 9 | 66993-963 |
|---|---|
| NDC 10 | 66993-963-89 |
| NDC Item | 66993096389 |
| Packaging | 1 BOTTLE, WITH APPLICATOR in 1 CARTON (66993-963-89) / 90 mL in 1 BOTTLE, WITH APPLICATOR |
| DCSA | CIII |
| FDA SPL set id | 327477 |
| Labeler | Prasco Laboratories |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time high | 2018-12-31 |
| Marketing effective time low | 2017-01-23 |
| Marketing status | COMPLETED |
| NDA_AUTHORIZED_GENERIC | NDA022504 |
| Related queries | Properties for NDC 9 66993-963 |
NDC Item 68180094311
| NDC 9 | 68180-943 |
|---|---|
| NDC 10 | 68180-943-11 |
| NDC Item | 68180094311 |
| Packaging | 1 BOTTLE, WITH APPLICATOR in 1 CARTON (68180-943-11) / 90 mL in 1 BOTTLE, WITH APPLICATOR |
| ANDA | ANDA208061 |
| DCSA | CIII |
| FDA SPL set id | 468196 |
| Labeler | Lupin Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2018-02-23 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68180-943 |
NDC Item 69097036344
| NDC 9 | 69097-363 |
|---|---|
| NDC 10 | 69097-363-44 |
| NDC Item | 69097036344 |
| Packaging | 1 BOTTLE in 1 CARTON (69097-363-44) / 90 mL in 1 BOTTLE |
| ANDA | ANDA209533 |
| DCSA | CIII |
| FDA SPL set id | 497849 |
| Labeler | Cipla USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2018-03-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 69097-363 |
NDC Item 69339015810
| NDC 9 | 69339-158 |
|---|---|
| NDC 10 | 69339-158-10 |
| NDC Item | 69339015810 |
| Packaging | 1 BOTTLE in 1 CARTON (69339-158-10) / 110 mL in 1 BOTTLE |
| ANDA | ANDA212301 |
| DCSA | CIII |
| FDA SPL set id | 776899 |
| Labeler | NATCO Pharma USA LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2024-03-31 |
| Marketing effective time low | 2021-07-12 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 69339-158 |
NDC Item 72162142102
| NDC 9 | 72162-1421 |
|---|---|
| NDC 10 | 72162-1421-2 |
| NDC Item | 72162142102 |
| Packaging | 1 BOTTLE, PUMP in 1 CARTON (72162-1421-2) / 110 mL in 1 BOTTLE, PUMP |
| ANDA | ANDA204255 |
| DCSA | CIII |
| FDA SPL set id | 793241 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-06-28 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72162-1421 |
NDC Item 00591211481
| NDC 9 | 0591-2114 |
|---|---|
| NDC 10 | 0591-2114-81 |
| NDC Item | 00591211481 |
| Packaging | 1 BOTTLE, WITH APPLICATOR in 1 CARTON (0591-2114-81) / 90 mL in 1 BOTTLE, WITH APPLICATOR |
| ANDA | ANDA205328 |
| DCSA | CIII |
| FDA SPL set id | 673536 |
| Labeler | Actavis Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-08-18 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0591-2114 |
NDC Item 24979013026
| NDC 9 | 24979-130 |
|---|---|
| NDC 10 | 24979-130-26 |
| NDC Item | 24979013026 |
| Packaging | 1 BOTTLE, PUMP in 1 CARTON (24979-130-26) / 110 mL in 1 BOTTLE, PUMP |
| ANDA | ANDA209836 |
| DCSA | CIII |
| FDA SPL set id | 750432 |
| Labeler | TWi Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-12-31 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 24979-130 |
NDC Item 45802061001
| NDC 9 | 45802-610 |
|---|---|
| NDC 10 | 45802-610-01 |
| NDC Item | 45802061001 |
| Packaging | 1 BOTTLE, PUMP in 1 CARTON (45802-610-01) / 110 mL in 1 BOTTLE, PUMP |
| ANDA | ANDA204255 |
| DCSA | CIII |
| FDA SPL set id | 700458 |
| Labeler | Padagis Israel Pharmaceuticals Ltd |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-06-28 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 45802-610 |
NDC Item 62332048811
| NDC 9 | 62332-488 |
|---|---|
| NDC 10 | 62332-488-11 |
| NDC Item | 62332048811 |
| Packaging | 1 BOTTLE, WITH APPLICATOR in 1 CARTON (62332-488-11) / 110 mL in 1 BOTTLE, WITH APPLICATOR |
| ANDA | ANDA212882 |
| DCSA | CIII |
| FDA SPL set id | 752837 |
| Labeler | Alembic Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-12-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 62332-488 |
NDC Item 63629931001
| NDC 9 | 63629-9310 |
|---|---|
| NDC 10 | 63629-9310-1 |
| NDC Item | 63629931001 |
| Packaging | 1 BOTTLE, PUMP in 1 CARTON (63629-9310-1) / 110 mL in 1 BOTTLE, PUMP |
| ANDA | ANDA204255 |
| DCSA | CIII |
| FDA SPL set id | 805065 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-06-28 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63629-9310 |
NDC Item 66993096389
| NDC 9 | 66993-963 |
|---|---|
| NDC 10 | 66993-963-89 |
| NDC Item | 66993096389 |
| Packaging | 1 BOTTLE, WITH APPLICATOR in 1 CARTON (66993-963-89) / 90 mL in 1 BOTTLE, WITH APPLICATOR |
| DCSA | CIII |
| FDA SPL set id | 327477 |
| Labeler | Prasco Laboratories |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time high | 2018-12-31 |
| Marketing effective time low | 2017-01-23 |
| Marketing status | COMPLETED |
| NDA_AUTHORIZED_GENERIC | NDA022504 |
| Related queries | Properties for NDC 9 66993-963 |
NDC Item 68180094311
| NDC 9 | 68180-943 |
|---|---|
| NDC 10 | 68180-943-11 |
| NDC Item | 68180094311 |
| Packaging | 1 BOTTLE, WITH APPLICATOR in 1 CARTON (68180-943-11) / 90 mL in 1 BOTTLE, WITH APPLICATOR |
| ANDA | ANDA208061 |
| DCSA | CIII |
| FDA SPL set id | 468196 |
| Labeler | Lupin Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2018-02-23 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68180-943 |
NDC Item 69097036344
| NDC 9 | 69097-363 |
|---|---|
| NDC 10 | 69097-363-44 |
| NDC Item | 69097036344 |
| Packaging | 1 BOTTLE in 1 CARTON (69097-363-44) / 90 mL in 1 BOTTLE |
| ANDA | ANDA209533 |
| DCSA | CIII |
| FDA SPL set id | 497849 |
| Labeler | Cipla USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2018-03-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 69097-363 |
NDC Item 69339015810
| NDC 9 | 69339-158 |
|---|---|
| NDC 10 | 69339-158-10 |
| NDC Item | 69339015810 |
| Packaging | 1 BOTTLE in 1 CARTON (69339-158-10) / 110 mL in 1 BOTTLE |
| ANDA | ANDA212301 |
| DCSA | CIII |
| FDA SPL set id | 776899 |
| Labeler | NATCO Pharma USA LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2024-03-31 |
| Marketing effective time low | 2021-07-12 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 69339-158 |
NDC Item 72162142102
| NDC 9 | 72162-1421 |
|---|---|
| NDC 10 | 72162-1421-2 |
| NDC Item | 72162142102 |
| Packaging | 1 BOTTLE, PUMP in 1 CARTON (72162-1421-2) / 110 mL in 1 BOTTLE, PUMP |
| ANDA | ANDA204255 |
| DCSA | CIII |
| FDA SPL set id | 793241 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-06-28 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72162-1421 |
NDC Item 00591211481
| NDC 9 | 0591-2114 |
|---|---|
| NDC 10 | 0591-2114-81 |
| NDC Item | 00591211481 |
| Packaging | 1 BOTTLE, WITH APPLICATOR in 1 CARTON (0591-2114-81) / 90 mL in 1 BOTTLE, WITH APPLICATOR |
| ANDA | ANDA205328 |
| DCSA | CIII |
| FDA SPL set id | 673536 |
| Labeler | Actavis Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-08-18 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0591-2114 |
NDC Item 24979013026
| NDC 9 | 24979-130 |
|---|---|
| NDC 10 | 24979-130-26 |
| NDC Item | 24979013026 |
| Packaging | 1 BOTTLE, PUMP in 1 CARTON (24979-130-26) / 110 mL in 1 BOTTLE, PUMP |
| ANDA | ANDA209836 |
| DCSA | CIII |
| FDA SPL set id | 750432 |
| Labeler | TWi Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-12-31 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 24979-130 |
NDC Item 45802061001
| NDC 9 | 45802-610 |
|---|---|
| NDC 10 | 45802-610-01 |
| NDC Item | 45802061001 |
| Packaging | 1 BOTTLE, PUMP in 1 CARTON (45802-610-01) / 110 mL in 1 BOTTLE, PUMP |
| ANDA | ANDA204255 |
| DCSA | CIII |
| FDA SPL set id | 700458 |
| Labeler | Padagis Israel Pharmaceuticals Ltd |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-06-28 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 45802-610 |
NDC Item 62332048811
| NDC 9 | 62332-488 |
|---|---|
| NDC 10 | 62332-488-11 |
| NDC Item | 62332048811 |
| Packaging | 1 BOTTLE, WITH APPLICATOR in 1 CARTON (62332-488-11) / 110 mL in 1 BOTTLE, WITH APPLICATOR |
| ANDA | ANDA212882 |
| DCSA | CIII |
| FDA SPL set id | 752837 |
| Labeler | Alembic Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-12-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 62332-488 |
NDC Item 63629931001
| NDC 9 | 63629-9310 |
|---|---|
| NDC 10 | 63629-9310-1 |
| NDC Item | 63629931001 |
| Packaging | 1 BOTTLE, PUMP in 1 CARTON (63629-9310-1) / 110 mL in 1 BOTTLE, PUMP |
| ANDA | ANDA204255 |
| DCSA | CIII |
| FDA SPL set id | 805065 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-06-28 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63629-9310 |
NDC Item 66993096389
| NDC 9 | 66993-963 |
|---|---|
| NDC 10 | 66993-963-89 |
| NDC Item | 66993096389 |
| Packaging | 1 BOTTLE, WITH APPLICATOR in 1 CARTON (66993-963-89) / 90 mL in 1 BOTTLE, WITH APPLICATOR |
| DCSA | CIII |
| FDA SPL set id | 327477 |
| Labeler | Prasco Laboratories |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time high | 2018-12-31 |
| Marketing effective time low | 2017-01-23 |
| Marketing status | COMPLETED |
| NDA_AUTHORIZED_GENERIC | NDA022504 |
| Related queries | Properties for NDC 9 66993-963 |
NDC Item 68180094311
| NDC 9 | 68180-943 |
|---|---|
| NDC 10 | 68180-943-11 |
| NDC Item | 68180094311 |
| Packaging | 1 BOTTLE, WITH APPLICATOR in 1 CARTON (68180-943-11) / 90 mL in 1 BOTTLE, WITH APPLICATOR |
| ANDA | ANDA208061 |
| DCSA | CIII |
| FDA SPL set id | 468196 |
| Labeler | Lupin Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2018-02-23 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68180-943 |
NDC Item 69097036344
| NDC 9 | 69097-363 |
|---|---|
| NDC 10 | 69097-363-44 |
| NDC Item | 69097036344 |
| Packaging | 1 BOTTLE in 1 CARTON (69097-363-44) / 90 mL in 1 BOTTLE |
| ANDA | ANDA209533 |
| DCSA | CIII |
| FDA SPL set id | 497849 |
| Labeler | Cipla USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2018-03-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 69097-363 |
NDC Item 69339015810
| NDC 9 | 69339-158 |
|---|---|
| NDC 10 | 69339-158-10 |
| NDC Item | 69339015810 |
| Packaging | 1 BOTTLE in 1 CARTON (69339-158-10) / 110 mL in 1 BOTTLE |
| ANDA | ANDA212301 |
| DCSA | CIII |
| FDA SPL set id | 776899 |
| Labeler | NATCO Pharma USA LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2024-03-31 |
| Marketing effective time low | 2021-07-12 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 69339-158 |
NDC Item 72162142102
| NDC 9 | 72162-1421 |
|---|---|
| NDC 10 | 72162-1421-2 |
| NDC Item | 72162142102 |
| Packaging | 1 BOTTLE, PUMP in 1 CARTON (72162-1421-2) / 110 mL in 1 BOTTLE, PUMP |
| ANDA | ANDA204255 |
| DCSA | CIII |
| FDA SPL set id | 793241 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-06-28 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72162-1421 |
NDC Item 00591211481
| NDC 9 | 0591-2114 |
|---|---|
| NDC 10 | 0591-2114-81 |
| NDC Item | 00591211481 |
| Packaging | 1 BOTTLE, WITH APPLICATOR in 1 CARTON (0591-2114-81) / 90 mL in 1 BOTTLE, WITH APPLICATOR |
| ANDA | ANDA205328 |
| DCSA | CIII |
| FDA SPL set id | 673536 |
| Labeler | Actavis Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-08-18 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0591-2114 |
NDC Item 24979013026
| NDC 9 | 24979-130 |
|---|---|
| NDC 10 | 24979-130-26 |
| NDC Item | 24979013026 |
| Packaging | 1 BOTTLE, PUMP in 1 CARTON (24979-130-26) / 110 mL in 1 BOTTLE, PUMP |
| ANDA | ANDA209836 |
| DCSA | CIII |
| FDA SPL set id | 750432 |
| Labeler | TWi Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-12-31 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 24979-130 |
NDC Item 45802061001
| NDC 9 | 45802-610 |
|---|---|
| NDC 10 | 45802-610-01 |
| NDC Item | 45802061001 |
| Packaging | 1 BOTTLE, PUMP in 1 CARTON (45802-610-01) / 110 mL in 1 BOTTLE, PUMP |
| ANDA | ANDA204255 |
| DCSA | CIII |
| FDA SPL set id | 700458 |
| Labeler | Padagis Israel Pharmaceuticals Ltd |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-06-28 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 45802-610 |
NDC Item 62332048811
| NDC 9 | 62332-488 |
|---|---|
| NDC 10 | 62332-488-11 |
| NDC Item | 62332048811 |
| Packaging | 1 BOTTLE, WITH APPLICATOR in 1 CARTON (62332-488-11) / 110 mL in 1 BOTTLE, WITH APPLICATOR |
| ANDA | ANDA212882 |
| DCSA | CIII |
| FDA SPL set id | 752837 |
| Labeler | Alembic Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-12-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 62332-488 |
NDC Item 63629931001
| NDC 9 | 63629-9310 |
|---|---|
| NDC 10 | 63629-9310-1 |
| NDC Item | 63629931001 |
| Packaging | 1 BOTTLE, PUMP in 1 CARTON (63629-9310-1) / 110 mL in 1 BOTTLE, PUMP |
| ANDA | ANDA204255 |
| DCSA | CIII |
| FDA SPL set id | 805065 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-06-28 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63629-9310 |
NDC Item 66993096389
| NDC 9 | 66993-963 |
|---|---|
| NDC 10 | 66993-963-89 |
| NDC Item | 66993096389 |
| Packaging | 1 BOTTLE, WITH APPLICATOR in 1 CARTON (66993-963-89) / 90 mL in 1 BOTTLE, WITH APPLICATOR |
| DCSA | CIII |
| FDA SPL set id | 327477 |
| Labeler | Prasco Laboratories |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time high | 2018-12-31 |
| Marketing effective time low | 2017-01-23 |
| Marketing status | COMPLETED |
| NDA_AUTHORIZED_GENERIC | NDA022504 |
| Related queries | Properties for NDC 9 66993-963 |
NDC Item 68180094311
| NDC 9 | 68180-943 |
|---|---|
| NDC 10 | 68180-943-11 |
| NDC Item | 68180094311 |
| Packaging | 1 BOTTLE, WITH APPLICATOR in 1 CARTON (68180-943-11) / 90 mL in 1 BOTTLE, WITH APPLICATOR |
| ANDA | ANDA208061 |
| DCSA | CIII |
| FDA SPL set id | 468196 |
| Labeler | Lupin Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2018-02-23 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68180-943 |
NDC Item 69097036344
| NDC 9 | 69097-363 |
|---|---|
| NDC 10 | 69097-363-44 |
| NDC Item | 69097036344 |
| Packaging | 1 BOTTLE in 1 CARTON (69097-363-44) / 90 mL in 1 BOTTLE |
| ANDA | ANDA209533 |
| DCSA | CIII |
| FDA SPL set id | 497849 |
| Labeler | Cipla USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2018-03-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 69097-363 |
NDC Item 69339015810
| NDC 9 | 69339-158 |
|---|---|
| NDC 10 | 69339-158-10 |
| NDC Item | 69339015810 |
| Packaging | 1 BOTTLE in 1 CARTON (69339-158-10) / 110 mL in 1 BOTTLE |
| ANDA | ANDA212301 |
| DCSA | CIII |
| FDA SPL set id | 776899 |
| Labeler | NATCO Pharma USA LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2024-03-31 |
| Marketing effective time low | 2021-07-12 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 69339-158 |
NDC Item 72162142102
| NDC 9 | 72162-1421 |
|---|---|
| NDC 10 | 72162-1421-2 |
| NDC Item | 72162142102 |
| Packaging | 1 BOTTLE, PUMP in 1 CARTON (72162-1421-2) / 110 mL in 1 BOTTLE, PUMP |
| ANDA | ANDA204255 |
| DCSA | CIII |
| FDA SPL set id | 793241 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-06-28 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72162-1421 |
NDC Item 00591211481
| NDC 9 | 0591-2114 |
|---|---|
| NDC 10 | 0591-2114-81 |
| NDC Item | 00591211481 |
| Packaging | 1 BOTTLE, WITH APPLICATOR in 1 CARTON (0591-2114-81) / 90 mL in 1 BOTTLE, WITH APPLICATOR |
| ANDA | ANDA205328 |
| DCSA | CIII |
| FDA SPL set id | 673536 |
| Labeler | Actavis Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-08-18 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0591-2114 |
NDC Item 24979013026
| NDC 9 | 24979-130 |
|---|---|
| NDC 10 | 24979-130-26 |
| NDC Item | 24979013026 |
| Packaging | 1 BOTTLE, PUMP in 1 CARTON (24979-130-26) / 110 mL in 1 BOTTLE, PUMP |
| ANDA | ANDA209836 |
| DCSA | CIII |
| FDA SPL set id | 750432 |
| Labeler | TWi Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-12-31 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 24979-130 |
NDC Item 45802061001
| NDC 9 | 45802-610 |
|---|---|
| NDC 10 | 45802-610-01 |
| NDC Item | 45802061001 |
| Packaging | 1 BOTTLE, PUMP in 1 CARTON (45802-610-01) / 110 mL in 1 BOTTLE, PUMP |
| ANDA | ANDA204255 |
| DCSA | CIII |
| FDA SPL set id | 700458 |
| Labeler | Padagis Israel Pharmaceuticals Ltd |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-06-28 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 45802-610 |
NDC Item 62332048811
| NDC 9 | 62332-488 |
|---|---|
| NDC 10 | 62332-488-11 |
| NDC Item | 62332048811 |
| Packaging | 1 BOTTLE, WITH APPLICATOR in 1 CARTON (62332-488-11) / 110 mL in 1 BOTTLE, WITH APPLICATOR |
| ANDA | ANDA212882 |
| DCSA | CIII |
| FDA SPL set id | 752837 |
| Labeler | Alembic Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-12-08 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 62332-488 |
NDC Item 63629931001
| NDC 9 | 63629-9310 |
|---|---|
| NDC 10 | 63629-9310-1 |
| NDC Item | 63629931001 |
| Packaging | 1 BOTTLE, PUMP in 1 CARTON (63629-9310-1) / 110 mL in 1 BOTTLE, PUMP |
| ANDA | ANDA204255 |
| DCSA | CIII |
| FDA SPL set id | 805065 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-06-28 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63629-9310 |
NDC Item 66993096389
| NDC 9 | 66993-963 |
|---|---|
| NDC 10 | 66993-963-89 |
| NDC Item | 66993096389 |
| Packaging | 1 BOTTLE, WITH APPLICATOR in 1 CARTON (66993-963-89) / 90 mL in 1 BOTTLE, WITH APPLICATOR |
| DCSA | CIII |
| FDA SPL set id | 327477 |
| Labeler | Prasco Laboratories |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time high | 2018-12-31 |
| Marketing effective time low | 2017-01-23 |
| Marketing status | COMPLETED |
| NDA_AUTHORIZED_GENERIC | NDA022504 |
| Related queries | Properties for NDC 9 66993-963 |
NDC Item 68180094311
| NDC 9 | 68180-943 |
|---|---|
| NDC 10 | 68180-943-11 |
| NDC Item | 68180094311 |
| Packaging | 1 BOTTLE, WITH APPLICATOR in 1 CARTON (68180-943-11) / 90 mL in 1 BOTTLE, WITH APPLICATOR |
| ANDA | ANDA208061 |
| DCSA | CIII |
| FDA SPL set id | 468196 |
| Labeler | Lupin Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2018-02-23 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68180-943 |
NDC Item 69097036344
| NDC 9 | 69097-363 |
|---|---|
| NDC 10 | 69097-363-44 |
| NDC Item | 69097036344 |
| Packaging | 1 BOTTLE in 1 CARTON (69097-363-44) / 90 mL in 1 BOTTLE |
| ANDA | ANDA209533 |
| DCSA | CIII |
| FDA SPL set id | 497849 |
| Labeler | Cipla USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2018-03-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 69097-363 |
NDC Item 69339015810
| NDC 9 | 69339-158 |
|---|---|
| NDC 10 | 69339-158-10 |
| NDC Item | 69339015810 |
| Packaging | 1 BOTTLE in 1 CARTON (69339-158-10) / 110 mL in 1 BOTTLE |
| ANDA | ANDA212301 |
| DCSA | CIII |
| FDA SPL set id | 776899 |
| Labeler | NATCO Pharma USA LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2024-03-31 |
| Marketing effective time low | 2021-07-12 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 69339-158 |
NDC Item 72162142102
| NDC 9 | 72162-1421 |
|---|---|
| NDC 10 | 72162-1421-2 |
| NDC Item | 72162142102 |
| Packaging | 1 BOTTLE, PUMP in 1 CARTON (72162-1421-2) / 110 mL in 1 BOTTLE, PUMP |
| ANDA | ANDA204255 |
| DCSA | CIII |
| FDA SPL set id | 793241 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-06-28 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72162-1421 |